Planatome developed patented surface modification technology based on chemical mechanical planarization that it applies to surgical blades. When applied in the medical field, the process improves surface smoothness by a factor of 1,000 or more, producing low‑trauma, high‑precision cutting tools. Its blades have approval for use in the United States and South Korea and have recently been adopted by several hospitals and surgicenters. The company intends to use the new funding to hire commercial talent, expand manufacturing capacity, and create new business lines deploying its polishing technology across surgical cutting instruments. Planned applications include surgical scissors, laparoscopic tools, and robotic end effectors, and the technology can be adapted to other industries that could benefit from atomically smooth surfaces. The company is led by CEO Tim Tobin.

Total raised

$6M

Funding rounds

2

Latest round

Convertible Note

Latest activity

Oct 2023